Strategic Section 112 Considerations for Japanese Companies in the Hi-tech and Bio-pharm Industries

35 U.S.C. § 112 of U.S. patent law outlines several requirements of a U.S. patent, and they are important considerations for drafting and prosecuting a patent application as well as litigating a patent.  With the advent of new technologies, we have been faced with new challenges in complying with the long-standing requirements.  This is true for Japanese companies involved in the fields of hi-tech and bio-pharm. 

This webinar will discuss strategic considerations in complying with Section 112 requirements.  We will address a few of the requirements from hi-tech and bio-pharm perspectives.

Topics to be discussed include:

• Written Description Support for Antibody Claims
• Functional Claiming for the Hi-tech Industry
• Other Key Strategic Considerations

This webinar will be presented in Japanese.

Recorded: View On Demand

Speakers:
Chiaki Kobayashi
Naoki Yoshida

Time:
10:00 – 11:00 a.m. Japan